Trial Profile
A clinical study to evaluate the efficacy, immunogenicity, and safety of various regimens using two different formulations of RTS,S (GSK-257049)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 257049 (Primary)
- Indications Malaria
- Focus Therapeutic Use
- Sponsors GSK
- 23 Nov 2017 New trial record